PDPL.NS
Parenteral Drugs (India) Limited [PDPL.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PDPL.NS Stock Summary
In the News
PDPL.NS Financial details
Company Rating
-
Market Cap
101.08M
Income
-763.62M
Revenue
84.96M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
909
Optionable
No
Shortable
Yes
Earnings
-
P/E
-0.11
Forward P/E
-
PEG
0.03
P/S
1.19
P/B
-0.01
P/C
-
P/FCF
-20.94
Quick Ratio
0.01
Current Ratio
0.06
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-25.6
EPS next Y
-
EPS next Q
-
EPS this Y
-37.26%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-8.48%
Revenue last 5Y
-47.68%
Revenue Q/Q
22.94%
EPS Q/Q
-169%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-16%
ROE
10%
ROC
-
Gross Margin
36%
Oper. Margin
-1%
Profit Margin
-899%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.7-4.8
52W High
-27.5%
52W Low
+45%
RSI
-
Rel Volume
4.88
Avg Volume
218
Volume
1.06K
Perf Week
0%
Perf Month
-
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
0.184
-
-
Volatility
0%, 0%
Prev Close
0%
Price
2.9
Change
7.41%
Company Profile
- Volume Average 218
- Market Capitalization 101.08M
- Employee 909
- CEO Mr. Govind Das Garg B.Tech.
- Headquarters Indore,IN
- IPO Date 2010-08-19
-
Website
https://www.pdindia.com 
Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anaesthesia products. The company also exports its products to Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. The company was incorporated in 1983 and is based in Indore, India.
